Stay updated with breaking news from Lymphocyte Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celyad Oncology reports third quarter 2023 financial results and recent business highlights ...
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging progress in multiplex shRNA platform development, which allows now targeting of up to four genes simultaneously, were...
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement commitments from historical shareholdersEncouraging...
Georges Rawadi was appointed Chief Executive Officer as from April 27, 2023Celyad Oncology has received approximately EUR 9.8m in private placement...